Interview with the President and CEO: Signal Genetics, Inc. (SGNL)

Healthcare >> CEO Interviews >> April 8, 2015

Samuel D. Riccitelli has served as the President and Chief Executive Officer and a member of the board of directors of Signal Genetics, Inc., since October 2012. From July 2011 to October 2012, he was an independent consultant. From October 2001 to June 2011, Mr. Riccitelli served as the Executive Vice President and Chief Operating Officer of Genoptix, Inc., a publicly traded diagnostic services company focused on the needs of community hematologists and oncologists. From 1995 to 2001, Mr. Riccitelli served in a number of positions for Becton, Dickinson and Company, including most recently as a vice president and general manager, and as a board member for BD Ventures, L.L.C., a venture capital fund. From 1989 to 1994, he served in a number of positions at Puritan-Bennett Corporation, including most recently as General Manager. Mr. Riccitelli also served on the board of directors of Exagen Diagnostics, Inc., from October 2011 to September 2014. Mr. Riccitelli received a B.A. in biology from Washington and Jefferson College, and an M.S. in engineering degree from The University of Texas in mechanical and biomedical engineering. Profile

TWST: Let's start, if you would, by telling us a bit about Signal Genetics’ founding and history?

Mr. Riccitelli: Signal Genetics was founded in 2010. The genesis of the company

Join for free to read a longer excerpt or purchase this article

Interview with the President and CEO: Signal Genetics, Inc. (SGNL)

Top Company Interviews

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS

Interview with the President and CEO: Signal Genetics, Inc. (SGNL)

Top Company Interviews

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS